Direct

Sep 26, 2013

Comments

Post a Comment You must be signed in to leave a comment. To sign in or create an account, enter your email address and we'll send you a one-click sign-in link.

Loading comments...

Michael J. Cannavo.

The PACSman Pontificates: Should AI be free?

June 2, 2025

Pxl 20250531 175048475~2

Radium-223 safety confirmed in long-term study

June 2, 2025

Register today for our June 17 webinar

Register today for our June 17 webinar

June 3, 2025

Prostate Imaging

Pluvicto shows promise in combination with standard treatments

June 2, 2025

The PACSman Pontificates: Should AI be free?

By Michael J. Cannavo

In a new column, consultant Michael J. Cannavo, aka the PACSman, shares his take on whether radiology AI should be free.

June 2, 2025

Michael J. Cannavo.

Radium-223 safety confirmed in long-term study

By Erik L. Ridley

At ASCO 2025, researchers shared data on the long-term safety of Ra-223 treatments for metastatic castration-resistant prostate cancer.

June 2, 2025

Pxl 20250531 175048475~2

PET reveals brain differences in people with alcohol abuse disorder

Women but not men with alcohol use disorder have lower levels of protein involved in the brain’s immune response.

June 2, 2025

Pluvicto shows promise in combination with standard treatments

By AuntMinnie.com staff writers

Novartis has announced that Pluvicto shows promise in patients in an earlier setting.

June 2, 2025

Prostate Imaging

MRI-based fusion model determines HER2 status in breast cancer

By Amerigo Allegretto

An MRI-based fusion radiomics model achieved high accuracy in determining HER2 status in breast cancer patients.

June 2, 2025

The results depict tumor segmentation. an example of HER2 positive breast cancer is shown: (A), (B), and (C) represent the segmentation results of the entire tumor region on the T2WI, DCE-MRI, and DWI sequences, respectively; (D), (E), And (F) show the segmentation results of the intratumoral region combined with 3 mm peritumoral area on the T2WI, DCE-MRI, and DWI sequences, respectively.

Mobile mammography units face diagnostic challenges

By AuntMinnie.com staff writers

There are opportunities to improve the service provided by mobile mammography units, according to research presented at ASCO 2025 in Chicago.

June 1, 2025

Pxl 20250531 175048475~2

MRI radiomics helps predict liver cancer treatment response

By AuntMinnie.com staff writers

A study presented at ASCO 2025 highlighted the benefits of MRI radiomics analysis in predicting treatment response in patients with advanced liver cancer.

June 1, 2025

Pxl 20250531 175048475~2

Experts weigh in on prior authorization reform bill

By Amerigo Allegretto

Imaging experts are weighing in on a bill recently reintroduced into Congress that addresses current prior authorization practices.

May 30, 2025

Insurance Policy 400 (1)

Explainable DL MRI model shows promise diagnosing liver cancer

An AI model not only classifies liver lesions but also provides visual explanations for its decisions.

May 30, 2025

A graphical abstract of the study.

ACS highlights prevalence of breast, lung cancer over the next decade

More women will survive breast cancer and lung cancer faces better survival rates, though notable disparities remain.

May 30, 2025

Estimated numbers of survivors of cancer in the U.S. by state as of January 1, 2025.

Breast cancer screening starting at age 40 leads to better outcomes

By Amerigo Allegretto

Breast cancers detected by screening led to lower odds of advanced cancers and cancer-related deaths than symptom-detected cancers.

May 30, 2025

Mammogram Calendar 400

Will FAP-targeted theranostics live up to their promise?

Fibroblast activation protein (FAP)-targeted theranostics is an emerging technique in the battle against cancer.

May 29, 2025

Fap Theranostics

Page 1 of 142